AFIB - Acutus Medical Non-GAAP EPS beats revenue misses guidance in-line with consensus
- Acutus Medical press release ( NASDAQ: AFIB ): Q3 Non-GAAP EPS of $0.70 beats by $1.44 .
- Revenue of $3.6M (-21.7% Y/Y) misses by $0.04M .
- The company now expects FY22 revenue to be in a range from $15.5-$16.0 million, vs. consensus of $15.98M.
For further details see:
Acutus Medical Non-GAAP EPS beats, revenue misses, guidance in-line with consensus